PA Home | Positively Aware en Español | HIV Drug Guide | HIV Services Directory | Subscribe | Advertise | Editorial Policy | Archives
The Journal of Test Positive Aware Network


Jan/Feb Issue Home

Download PDF Version

Download Drug Chart PDF

Departments

Articles
 
12th Annual HIV Drug Guide

Updated by Mariela Diaz-Linares, Pharm.D. and Enid Vázquez
Doctor’s statements by Joel Gallant, MD, MPH
Activist’s statements by Martin Delaney

A quick guide to using this guide
by Jeff Berry
  • Drugs are color-coded by class; drugs are listed alphabetically within each class by brand name.
  • Fixed-dose combinations (FDC) are formulations that combine two or more drugs, and are marked “Combo Drug.”
  • The Average Wholesale Price (AWP) is an industry standard that pharmacies and other buyers use to negotiate the amount they pay for drugs. The AWP is included as a way to compare drug prices. It is not what you would pay out-of-pocket.
  • Drugs included in the HIV Drug Guide are those that are FDA-approved, or available in expanded access. Note: Last year Agenerase (amprenavir) was discontinued and removed from the market (an improved formulation, Lexiva, is available which is better absorbed and requires fewer pills).
  • The side effects and drug interactions charts make it easier to quickly find some of the more common side effects associated with each drug. Always refer to the individual drug pages, the manufacturer’s package insert, and your physician or pharmacist for more information on drug side effects and drug-drug interactions.
  • Our special pull-out chart allows you to easily pinpoint dosing information and food and liquid qualifications for each drug. (Intelence is missing because it was not yet approved when the chart was printed.) Refer to the drug pages or package insert for more information.
  • The U.S. Department of Health and Human Services (DHHS) Treatment Guidelines are periodically updated by a panel of experts. The complete document is available online and contains comprehensive and detailed guidelines on treatment strategies, lab tests, when to start, what to use, special populations, and co-infection.
  • Expanded versions of many of the activist’s comments, including views on drug development, are available online at www.tpan.com.


Drug Guide
Drug
Nucleoside Analog Reverse Transcriptase Inhibitors (NRTIs) or “Nukes”
Combivir (Epivir/Retrovir)
Emtriva (emtricitabine, FTC)
Epivir (lamivudine, 3TC)
Epzicom (Epivir/Ziagen)
Retrovir (zidovudine, AZT)
Trizivir (Epivir/Retrovir/Ziagen)
Truvada (Emtriva/Viread)
Videx & Videx EC (didanosine, ddI)
Viread (tenofovir)
Zerit (d4T)
Ziagen (abacavir)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or “Non-Nukes”
Intelence (etravirine, TMC-125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Dual-Class Fixed Dose Combination
Atripla (Sustiva/Truvada [Emtriva plus Viread])
Protease Inhibitors (PIs)
Aptivus (tipranavir)
Crixivan (indinavir sulfate)
Invirase (saquinavir)
Kaletra (lopinavir/ritonavir)
Lexiva (fos-amprenavir)
Norvir (ritonavir)
Prezista (darunavir)
Reyataz (atazanavir)
Viracept (nelfinavir)
Entry Inhibitors
Fuzeon (enfuvirtide, T-20)
Selzentry (maraviroc)
Integrase Inhibitor
Isentress (raltegravir)

 

This site contains HIV prevention messages that may not be appropriate for all audiences. Since HIV infection is spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this website.

Este sitio del web contiene mensajes de la prevención del VIH que pueden no ser appropiados para todas las audiencias. Puesto que la infección del VIH es propagada sobre todo con prácticas sexuales o por compartiendo jeringas, los mensajes y los programas de la prevención pueden dirigirse a estos asuntos. Si usted no está buscando tal información o puede ser ofendido por tales materiales, salga por favor de este website.

Opinions expressed in Positively Aware, Positively Aware en Español, or tpan.com are not necessarily those of staff or membership of Test Positive Aware Network (TPAN), its supporters and sponsors, or distributing agencies. Information, resources, and advertising in Positively Aware, Positively Aware en Español, or tpan.com do not constitute endorsement or recommendation of any medical treatment or product.

TPAN recommends that all medical treatments or products be discussed thoroughly and frankly with a licensed and fully HIV-informed medical practitioner, preferably a personal physician.

Although Positively Aware, Positively Aware en Español, and tpan.com take great care to ensure the accuracy of all the information that it presents, Positively Aware, Positively Aware en Español, and tpan.com staff and volunteers, TPAN, or the institutions and personnel who provide us with information cannot be held responsible for any damages, direct or consequential, that arise from use of this material or due to errors contained herein.